Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Bitcoin price likely to drop further, possibly below $40,000 before late 2026, says Galaxy Digital.

Market News
12 Jun 2026
Finbold
View Source
Bearish
pluang ai news

Galaxy Digital reports that Bitcoin's price has not yet hit its cycle bottom and is expected to fall further, potentially reaching between $40,000 and $46,000 before Q4 2026. The current decline is deeper than previous mild drops but still shallower than historic bear markets, which saw 77%-85% drops. Galaxy also presents scenarios where Bitcoin could fall as low as $30,000 or hold steady near $51,000-$54,000, depending on market conditions and institutional buying. This outlook highlights ongoing volatility and the importance of monitoring market trends for investors.

More News

SpaceX prioritizes growth over profits, following Amazon's strategy to build future value.

SpaceX prioritizes growth over profits, following Amazon's strategy to build future value.

SpaceX is choosing to focus on long-term growth rather than immediate profitability, similar to Amazon's approach in its early years. Experts say SpaceX could be profitable now if it reduced spending on projects like Starship and AI infrastructure, b...

Market News
Bullish
58 minutes ago
Cornerstone expands free sustainability data with updated EPA GHG Emission Factors Hub for scopes 1, 2, and 3 emissions.

Cornerstone expands free sustainability data with updated EPA GHG Emission Factors Hub for scopes 1, 2, and 3 emissions.

Cornerstone has released an updated version of the EPA's GHG Emission Factors Hub, providing free, consolidated data for scopes 1, 2, and 3 greenhouse gas emissions. This update includes new factors for air travel, refrigerants, and aligns with the l...

Others
Bullish
1 hour ago
New data show Lyell's ronde-cel CAR T-cell therapy is safe and effective for large B-cell lymphoma.

New data show Lyell's ronde-cel CAR T-cell therapy is safe and effective for large B-cell lymphoma.

Lyell Immunopharma presented updated safety and translational data for its CAR T-cell therapy, ronde-cel, in treating relapsed or refractory large B-cell lymphoma (LBCL). Over 100 patients treated showed no severe cytokine release syndrome (CRS) and ...

Market News
Bullish
2 hours ago
Ascendis Pharma's TransCon PTH shows 5-year success in hypoparathyroidism treatment, boosting stock.

Ascendis Pharma's TransCon PTH shows 5-year success in hypoparathyroidism treatment, boosting stock.

Ascendis Pharma reported positive five-year results from its Phase 2 PaTH Forward trial of TransCon PTH (palopegteriparatide) for adult hypoparathyroidism. The therapy maintained stable calcium levels, kidney and bone health, and quality of life, all...

Company Fundamentals
Bullish
2 hours ago
SpaceX shares debut at $150, rising to $165, valuing the company near $2 trillion.

SpaceX shares debut at $150, rising to $165, valuing the company near $2 trillion.

SpaceX began trading on the stock market at $150 per share, above its IPO price of $135, marking the largest public offering in history and valuing the company at about $1.96 trillion. The shares quickly rose to $165, reflecting strong demand that ex...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App